Pulse Biosciences (PLSE) Revenue (2021 - 2025)

Pulse Biosciences' quarterly Revenue came in at $86000.0 in Q3 2025, up 1055.56% quarter-over-quarter from -$9000.0 in Q4 2022.

Pulse Biosciences has reported Revenue for 3 years, with the latest figure at $86000.0 in Q3 2025.

  • For the quarter ending Q3 2025, Revenue changed N/A year-over-year to $86000.0; the trailing twelve-month figure through Sep 2025 stood at $86000.0 (changed N/A YoY), and the FY2022 full-year result was $700000.0, down 50.63% from the prior year.
  • Revenue for Q3 2025 stood at $86000.0, up from -$9000.0 in the prior quarter.
  • The five-year high for Revenue was $844000.0 in Q4 2021, with the low at -$9000.0 in Q4 2022.
  • Average Revenue over 3 years is $373166.7, with a median of $372000.0 recorded in 2022.
  • Peak annual rise in Revenue reached 101.07% in 2022, while the deepest fall reached 101.07% in 2022.
  • Tracing PLSE's Revenue over 3 years: stood at $844000.0 in 2021, then slumped by 101.07% to -$9000.0 in 2022, then jumped by 1055.56% to $86000.0 in 2025.
  • The last three Revenue figures came in at $86000.0 (Q3 2025), -$9000.0 (Q4 2022), and $300000.0 (Q2 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 2.77 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 4.71 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 1.43 Bn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 844.90 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 2.01 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 1.02 Bn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 1.04 Bn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 2.70 Bn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 982.87 Mn
10 Pulse Biosciences 1.72 Bn 1.72 Bn - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 86,000.00
Dec 31, 2022 -9,000.00
Jun 30, 2022 300,000.00
Mar 31, 2022 444,000.00
Dec 31, 2021 844,000.00
Sep 30, 2021 574,000.00